Diastolic wall strain predicts progression from paroxysmal to persistent or permanent atrial fibrillation in structurally normal hearts

被引:6
作者
Uetake, Shunsuke [1 ]
Maruyama, Mitsunori [1 ]
Mitsuishi, Tatsuya [1 ]
Takahashi, Kenta [1 ]
Miyauchi, Yasushi [1 ]
Seino, Yoshihiko [1 ]
Shimizu, Wataru [2 ]
机构
[1] Nippon Med Sch, Chiba Hokusoh Hosp, Dept Cardiovasc Med, Chiba, Japan
[2] Nippon Med Sch, Dept Cardiovasc Med, Tokyo, Japan
关键词
Atrial fibrillation; Progression; Prognosis; Echocardiography; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; RISK-FACTOR; ECHOCARDIOGRAPHY; RECOMMENDATIONS; STIFFNESS; REGISTRY; FAILURE; UPDATE; COHORT;
D O I
10.1016/j.jjcc.2019.03.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Atrial fibrillation (AF) is characterized by a progression from paroxysmal to persistent or permanent AF. Recent studies have shown that AF progression is related to a worse morbidity and mortality, and poorer outcomes of radiofrequency catheter ablation (RFCA). We previously showed that left ventricular (LV) compliance assessed by diastolic wall strain (DWS) was a strong determinant of prevalent AF. Methods and results: We studied 306 paroxysmal AF patients with structurally normal hearts. The DWS was non-invasively measured with echocardiography. During a follow-up of 35 +/- 19 months, AF progression occurred in 60 of 172 (35%) patients treated with medications only (medication group), and 3 of 134 (2%) who underwent RFCA (RFCA group) (p < 0.001). In the medication group, patients with a DWS <0.38 had a higher incidence of AF progression than those without (log-rank p < 0.001), while the AF progression rate was low irrespective of the DWS in the RFCA group. In a multivariate analysis, the DWS and left atrium volume index (LAVI) were independent predictors of AF progression in the medication group (hazard ratio, 1.13 per 0.01 decrease; 95% CI: 1.08-1.18; p < 0.001, and 1.04 per 1 mm increase; 95% CI: 1.01-1.08; p = 0.012, respectively). In the medication group, AF progression occurred in only 5 of 61 (8%) patients with a DWS >= 0.38, whereas 27 of 40 (68%) with a DWS <0.38 and LAVI >34 mL/m(2) progressed to persistent or permanent AF. Conclusions: The LV compliance estimated by the DWS was independently associated with AF progression. The DWS would be useful to stratify patients at risk of AF progression who could benefit from an earlier RFCA intervention. (C) 2019 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:339 / 346
页数:8
相关论文
共 27 条
[1]   Transition From Asymptomatic Diastolic Dysfunction to Heart Failure With Preserved Ejection Fraction - Roles of Systolic Function and Ventricular Distensibility [J].
Aizawa, Yoshihiro ;
Sakata, Yasushi ;
Mano, Toshiaki ;
Takeda, Yasuharu ;
Ohtani, Tomohito ;
Tamaki, Shunsuke ;
Omori, Yosuke ;
Tsukamoto, Yasumasa ;
Hirayama, Atsushi ;
Komuro, Issei ;
Yamamoto, Kazuhiro .
CIRCULATION JOURNAL, 2011, 75 (03) :596-602
[2]  
[Anonymous], GUIDELINES NONPHARMA
[3]   Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: Clinical correlates and the effect of rhythm-control therapy [J].
De Vos, Cees B. ;
Breithardt, Guenter ;
Camm, A. John ;
Dorian, Paul ;
Kowey, Peter R. ;
Le Heuzey, Jean-Yves ;
Naditch-Brule, Lisa ;
Prystowsky, Eric N. ;
Schwartz, Peter J. ;
Torp-Pedersen, Christian ;
Weintraub, William S. ;
Crijns, Harry J. .
AMERICAN HEART JOURNAL, 2012, 163 (05) :887-893
[4]   Progression From Paroxysmal to Persistent Atrial Fibrillation Clinical Correlates and Prognosis [J].
de Vos, Cees B. ;
Pisters, Ron ;
Nieuwlaat, Robby ;
Prins, Martin H. ;
Tieleman, Robert G. ;
Coelen, Robert-Jan S. ;
van den Heijkant, Antonius C. ;
Allessie, Maurits A. ;
Crijns, Harry J. G. M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (08) :725-731
[5]   Long-term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta-analysis [J].
Ganesan, Anand N. ;
Shipp, Nicholas J. ;
Brooks, Anthony G. ;
Kuklik, Pawel ;
Lau, Dennis H. ;
Lim, Han S. ;
Sullivan, Thomas ;
Roberts-Thomson, Kurt C. ;
Sanders, Prashanthan .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (02) :e004549
[6]  
Higuchi Koji, 2014, J Atr Fibrillation, V7, P1032, DOI 10.4022/jafib.1032
[7]   Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation [J].
Hirayama, Y ;
Atarashi, H ;
Kobayashi, Y ;
Horie, T ;
Iwasaki, Y ;
Maruyama, M ;
Miyauchi, Y ;
Ohara, T ;
Yashima, M ;
Takano, T .
CIRCULATION JOURNAL, 2005, 69 (06) :671-676
[8]   Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure [J].
Ichijo, Sadamitsu ;
Miyazaki, Shinsuke ;
Kusa, Shigeki ;
Nakamura, Hiroaki ;
Hachiya, Hitoshi ;
Kajiyama, Takatsugu ;
Iesaka, Yoshito .
JOURNAL OF CARDIOLOGY, 2018, 72 (3-4) :240-246
[9]  
January CT., 2014, J AM COLL CARDIOL
[10]   Progressive nature of paroxysmal atrial fibrillation - Observations from a 14-year follow-up study [J].
Kato, T ;
Yamashita, T ;
Sagara, K ;
Iinuma, H ;
Fu, LT .
CIRCULATION JOURNAL, 2004, 68 (06) :568-572